Literature DB >> 26990251

Unusually long duration and delayed penetrance in a family with FTD and mutation in MAPT (V337M).

Kimiko Domoto-Reilly1, Marie Y Davis1, C Dirk Keene2, Thomas D Bird1,3,4.   

Abstract

Mutations in the MAPT gene coding for the tau protein are one of the most common causes of familial frontotemporal dementia (FTD). In a previously described family with the V337M mutation in MAPT, we now report an affected woman who died at age 92 with a >40 year duration of symptoms, more than three times the mean disease duration in her family (13.8 years). Neuropathology showed the typical findings of a diffuse tauopathy. Conversely, her 67-year-old son with the same mutation remains asymptomatic more than 15 years beyond the mean age of onset in the family (51.5 years). These two cases demonstrate the marked variability in onset and duration of familial FTD and underscore the difficulties of discussing these issues with patients and families. The presumed genetic and environmental factors influencing these parameters remain largely unknown.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  MAPT; dementia; frontotemporal dementia; penetrance; tau

Mesh:

Substances:

Year:  2016        PMID: 26990251      PMCID: PMC5297469          DOI: 10.1002/ajmg.b.32443

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  18 in total

1.  Frontotemporal dementia progresses to death faster than Alzheimer disease.

Authors:  E D Roberson; J H Hesse; K D Rose; H Slama; J K Johnson; K Yaffe; M S Forman; C A Miller; J Q Trojanowski; J H Kramer; B L Miller
Journal:  Neurology       Date:  2005-09-13       Impact factor: 9.910

2.  The effects of APOE and tau gene variability on risk of frontotemporal dementia.

Authors:  L Bernardi; R G Maletta; C Tomaino; N Smirne; M Di Natale; M Perri; T Longo; R Colao; S A M Curcio; G Puccio; M Mirabelli; T Kawarai; E Rogaeva; P H St George Hyslop; G Passarino; G De Benedictis; A C Bruni
Journal:  Neurobiol Aging       Date:  2006-05       Impact factor: 4.673

3.  Chromosome 17 and hereditary dementia: linkage studies in three non-Alzheimer families and kindreds with late-onset FAD.

Authors:  T D Bird; E M Wijsman; D Nochlin; M Leehey; S M Sumi; H Payami; P Poorkaj; E Nemens; M Rafkind; G D Schellenberg
Journal:  Neurology       Date:  1997-04       Impact factor: 9.910

4.  Identification of misdiagnosed fronto-temporal dementia using APOE genotype and phenotype-genotype correlation analyses.

Authors:  Isabel Hernández; Ana Mauleón; Maiteé Rosense-Roca; Montserrat Alegret; Georgina Vinyes; Anna Espinosa; Oscar Sotolongo-Grau; James T Becker; Sergi Valero; Lluís Tarraga; Oscar L López; Agustín Ruiz; Mercè Boada
Journal:  Curr Alzheimer Res       Date:  2014-02       Impact factor: 3.498

5.  Frontotemporal lobar degeneration: demographic characteristics of 353 patients.

Authors:  Julene K Johnson; Janine Diehl; Mario F Mendez; John Neuhaus; Jill S Shapira; Mark Forman; Dennis J Chute; Erik D Roberson; Catherine Pace-Savitsky; Manuela Neumann; Tiffany W Chow; Howard J Rosen; Hans Forstl; Alexander Kurz; Bruce L Miller
Journal:  Arch Neurol       Date:  2005-06

6.  The APOE gene locus in frontotemporal dementia and primary progressive aphasia.

Authors:  Davide Seripa; Alessandra Bizzarro; Francesco Panza; Adele Acciarri; Fabio Pellegrini; Alberto Pilotto; Carlo Masullo
Journal:  Arch Neurol       Date:  2011-05

7.  Survival in frontotemporal dementia.

Authors:  J R Hodges; R Davies; J Xuereb; J Kril; G Halliday
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

8.  Genetic Modifiers of Age at Onset in Carriers of the G206A Mutation in PSEN1 With Familial Alzheimer Disease Among Caribbean Hispanics.

Authors:  Joseph H Lee; Rong Cheng; Badri Vardarajan; Rafael Lantigua; Dolly Reyes-Dumeyer; Ward Ortmann; Robert R Graham; Tushar Bhangale; Timothy W Behrens; Martin Medrano; Ivonne Z Jiménez-Velázquez; Richard Mayeux
Journal:  JAMA Neurol       Date:  2015-09       Impact factor: 18.302

9.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia.

Authors:  M G Spillantini; J R Murrell; M Goedert; M R Farlow; A Klug; B Ghetti
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

Review 10.  Frontotemporal dementia in elderly individuals.

Authors:  Atik Baborie; Tim D Griffiths; Evelyn Jaros; Parastoo Momeni; Ian G McKeith; David J Burn; G Keir; Andrew J Larner; David M Mann; Robert Perry
Journal:  Arch Neurol       Date:  2012-08
View more
  6 in total

1.  Lack of APOE Christchurch variant in five age of onset outliers with PSEN1, PSEN2 Alzheimer's disease and MAPT frontotemporal dementia.

Authors:  Chang-En Yu; Sunny Chen; Suman Jayadev; Thomas Bird
Journal:  J Neurol Sci       Date:  2020-09-18       Impact factor: 3.181

2.  Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers.

Authors:  Qin Chen; Bradley F Boeve; Christopher G Schwarz; Robert Reid; Nirubol Tosakulwong; Timothy G Lesnick; Jessica Bove; Patrick Brannelly; Danielle Brushaber; Giovanni Coppola; Christina Dheel; Bradford C Dickerson; Susan Dickinson; Kelley Faber; Julie Fields; Jamie Fong; Tatiana Foroud; Leah Forsberg; Ralitza H Gavrilova; Debra Gearhart; Nupur Ghoshal; Jill Goldman; Jonathan Graff-Radford; Neill R Graff-Radford; Murray Grossman; Dana Haley; Hilary W Heuer; Ging-Yuek R Hsiung; Edward Huey; David J Irwin; Clifford R Jack; David T Jones; Lynne Jones; Anna M Karydas; David S Knopman; John Kornak; Joel Kramer; Walter Kremers; Walter A Kukull; Maria Lapid; Diane Lucente; Codrin Lungu; Ian R A Mackenzie; Masood Manoochehri; Scott McGinnis; Bruce L Miller; Rodney Pearlman; Leonard Petrucelli; Madeline Potter; Rosa Rademakers; Eliana M Ramos; Katherine P Rankin; Katya Rascovsky; Pheth Sengdy; Leslie Shaw; Jeremy Syrjanen; Nadine Tatton; Joanne Taylor; Arthur W Toga; John Trojanowski; Sandra Weintraub; Bonnie Wong; Adam L Boxer; Howie Rosen; Zbigniew Wszolek; Kejal Kantarci
Journal:  Neurobiol Aging       Date:  2019-08-15       Impact factor: 4.673

3.  Genetic predictors of survival in behavioral variant frontotemporal degeneration.

Authors:  Carrie Caswell; Corey T McMillan; Sharon X Xie; Vivianna M Van Deerlin; EunRan Suh; Edward B Lee; John Q Trojanowski; Virginia M-Y Lee; David J Irwin; Murray Grossman; Lauren M Massimo
Journal:  Neurology       Date:  2019-09-19       Impact factor: 9.910

4.  Recent advances in the genetics of frontotemporal dementia.

Authors:  Daniel W Sirkis; Ethan G Geier; Luke W Bonham; Celeste M Karch; Jennifer S Yokoyama
Journal:  Curr Genet Med Rep       Date:  2019-01-30

5.  Frontal lobe 1H MR spectroscopy in asymptomatic and symptomatic MAPT mutation carriers.

Authors:  Qin Chen; Bradley F Boeve; Nirubol Tosakulwong; Timothy Lesnick; Danielle Brushaber; Christina Dheel; Julie Fields; Leah Forsberg; Ralitza Gavrilova; Debra Gearhart; Dana Haley; Jeffrey L Gunter; Jonathan Graff-Radford; David Jones; David Knopman; Neill Graff-Radford; Ruth Kraft; Maria Lapid; Rosa Rademakers; Jeremy Syrjanen; Zbigniew K Wszolek; Howie Rosen; Adam L Boxer; Kejal Kantarci
Journal:  Neurology       Date:  2019-07-17       Impact factor: 11.800

6.  Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.

Authors:  Shelley L Forrest; Jillian J Kril; Claire H Stevens; John B Kwok; Marianne Hallupp; Woojin S Kim; Yue Huang; Ciara V McGinley; Hellen Werka; Matthew C Kiernan; Jürgen Götz; Maria Grazia Spillantini; John R Hodges; Lars M Ittner; Glenda M Halliday
Journal:  Brain       Date:  2018-02-01       Impact factor: 13.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.